OGSIVEO 100 mg/1
nirogacestat · TABLET, FILM COATED · SpringWorks Therapeutics, Inc.
No Recall History
Plain English
OGSIVEO is a tablet, film coated containing nirogacestat at 100 mg/1, taken oral. Manufactured by SpringWorks Therapeutics, Inc..
Key Facts
- Brand Name
- OGSIVEO
- Generic Name
- nirogacestat
- NDC Code (Product)
82448-100- Manufacturer
- SpringWorks Therapeutics, Inc.
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA217677
- Drug Class
- Gamma Secretase Inhibitor [EPC]
- Marketing Start
- 11/27/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is OGSIVEO used for?
OGSIVEO contains nirogacestat. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is OGSIVEO a controlled substance?
OGSIVEO is not classified as a controlled substance by the DEA.
What is the generic name for OGSIVEO?
The generic name for OGSIVEO is nirogacestat. There are no other listed brand versions of nirogacestat.
What is the NDC code for OGSIVEO 100 mg/1?
The NDC (National Drug Code) for OGSIVEO 100 mg/1 is 82448-100, listed by SpringWorks Therapeutics, Inc..
Other OGSIVEO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)